Ardelyx (ARDX) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 20.65% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 69.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.41% |
| Dec 31, 2025 | 86.26% |
| Sep 30, 2025 | 90.33% |
| Jun 30, 2025 | 53.14% |
| Mar 31, 2025 | 48.09% |
| Dec 31, 2024 | 41.64% |
| Sep 30, 2024 | 59.24% |
| Jun 30, 2024 | 49.56% |
| Mar 31, 2024 | 35.12% |
| Dec 31, 2023 | 17.32% |
| Sep 30, 2023 | 11.35% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | -0.41% |
| Dec 31, 2022 | -4.51% |
| Sep 30, 2022 | -21.90% |
| Jun 30, 2022 | 19.16% |
| Mar 31, 2022 | 24.64% |
| Dec 31, 2021 | 15.55% |
| Sep 30, 2021 | 5.11% |
| Jun 30, 2021 | 7.34% |
| Mar 31, 2021 | 8.38% |
| Dec 31, 2020 | -2.04% |
| Sep 30, 2020 | 6.33% |
| Jun 30, 2020 | -1.41% |
| Mar 31, 2020 | 11.81% |
| Dec 31, 2019 | 12.59% |
| Sep 30, 2019 | 44.30% |
| Jun 30, 2019 | 14.35% |
| Mar 31, 2019 | 17.30% |
| Dec 31, 2018 | 43.78% |
| Sep 30, 2018 | 39.86% |
| Jun 30, 2018 | 59.54% |
| Mar 31, 2018 | 66.65% |
| Dec 31, 2017 | 28.93% |
| Sep 30, 2017 | 86.89% |
| Jun 30, 2017 | 204.31% |
| Mar 31, 2017 | 220.60% |
| Dec 31, 2016 | 176.91% |
| Sep 30, 2016 | 143.88% |
| Jun 30, 2016 | 150.31% |